Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 457,478
  • Shares Outstanding, K 38,379
  • Annual Sales, $ 122,370 K
  • Annual Income, $ -32,330 K
  • EBIT $ -58 M
  • EBITDA $ -49 M
  • 60-Month Beta 1.36
  • Price/Sales 3.89
  • Price/Cash Flow N/A
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 98.20% ( +31.33%)
  • Historical Volatility 75.47%
  • IV Percentile 85%
  • IV Rank 68.97%
  • IV High 136.12% on 10/25/24
  • IV Low 13.90% on 06/03/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 38
  • Volume Avg (30-Day) 128
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 2,081
  • Open Int (30-Day) 1,994

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.22 +1.96%
on 11/15/24
15.67 -26.99%
on 11/11/24
-1.04 (-8.33%)
since 10/15/24
3-Month
10.96 +4.38%
on 10/10/24
15.85 -27.85%
on 09/19/24
+0.09 (+0.79%)
since 08/15/24
52-Week
10.50 +8.95%
on 08/09/24
29.70 -61.48%
on 03/08/24
-10.83 (-48.63%)
since 11/15/23

Most Recent Stories

More News
Stock Index Futures Move Lower as U.S. Debt Ceiling Uncertainty Weighs on Sentiment, PMI Data in Focus

June S&P 500 futures (ESM23) are down -0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.02% this morning as the U.S. debt ceiling impasse kept risk sentiment fragile, while market participants...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
NKE : 76.66 (+1.29%)
BAER.Z.IX : 54.320 (+0.33%)
MYGN : 15.25 (-2.74%)
LFCR : 6.40 (-4.19%)
MVST : 0.7184 (-7.68%)
GH : 29.11 (-3.64%)
QTRX : 11.44 (-4.03%)
Quanterix’s First Quarter 2023 Earnings Conference Call

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, May 9, 2023, to discuss...

QTRX : 11.44 (-4.03%)
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that blood-based NfL measurements provided...

QTRX : 11.44 (-4.03%)
Quanterix to Participate in Barclays Global Healthcare Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays...

QTRX : 11.44 (-4.03%)
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended...

QTRX : 11.44 (-4.03%)
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s...

QTRX : 11.44 (-4.03%)
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss...

QTRX : 11.44 (-4.03%)
Mercy BioAnalytics Announces Executive Leadership Changes

Mercy BioAnalytics, Inc. , a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that Dawn Mattoon, PhD, has assumed the role of Chief Executive Officer...

QTRX : 11.44 (-4.03%)
TMO : 513.08 (-3.74%)
Quanterix Announces Appointment of Brian Blaser to Board of Directors

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective...

QTRX : 11.44 (-4.03%)
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory Developed...

QTRX : 11.44 (-4.03%)

Business Summary

Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa...

See More

Key Turning Points

3rd Resistance Point 12.63
2nd Resistance Point 12.31
1st Resistance Point 11.87
Last Price 11.44
1st Support Level 11.11
2nd Support Level 10.79
3rd Support Level 10.35

See More

52-Week High 29.70
Fibonacci 61.8% 22.37
Fibonacci 50% 20.10
Fibonacci 38.2% 17.83
Last Price 11.44
52-Week Low 10.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar